欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > SB 242235

商品分类

浏览历史

S84188

SB 242235

源叶(MedMol) 99%
  • 英文名:
  • SB 242235
  • 别名:
  • Kinome_3169; HMS3244I18; 4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine; HMS3244I17; HMS3244J17;
  • CAS号:
  • 193746-75-7
  • 分子式:
  • C19H20FN5O
  • 分子量:
  • 353.3934
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S84188-1mg 99% ¥295.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84188-2mg 99% ¥425.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84188-5mg 99% ¥690.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84188-10mg 99% ¥1180.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84188-25mg 99% ¥2500.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84188-50mg 99% ¥3700.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S84188-100mg 99% ¥5400.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: SB-242235 is a potent and selective p38 MAP kinase inhibitor, with an IC50 of 1.0 μM in primary human chondrocytes
  • 靶点: IC50: 1.0 μM (p38 MAPK, primary human chondrocytes)
  • 体外研究: SB 242235 (0-10 μM) dose-dependently inhibits the activation of MAPKAP K2 with an IC50 of 1.0 μM in human chondrocytes stimulated with IL-1β. SB 242235 inhibits intracellular p38 activity, MAPKAP K2 was then isolated from these cells and assayed using HSP27 as a substrate. Western Blot Analysis Cell Line: Human chondrocytes Concentration: 0 μM,0.01 μM,0.1 μM,1 μM,10 μM Incubation Time: 15 minutes Result: Dose-dependently inhibited the activation of MAPKAP K2 with an IC50 of 1.0 μM.
  • 体内研究: SB242235 (100 mg/kg; p.o.) abolishes MAP-KAPK-2 activity and HSP27 phosphorylation. SB242235 inhibits expression of the pro-inflammatory cytokines interleukin (IL)-6 and KC (murine IL-8) and COX-2. SB-242235 is demonstrated non-linear elimination kinetics that manifested as a decrease in clearance with increasing dose and apparent oral bioavailability > 100% at high oral doses in rat and monkey. Animal Model: Female SKH-1 hairless mice (4–6 weeks) Dosage: 100 mg/kg Administration: Oral administered, 30 minutes prior to ultraviolet B (UVB) irradiation Result: Abolished MAP-KAPK-2 activity and heat shock protein 27 (HSP27) phosphorylation.
  • 参考文献:
    1. Badger, A.M., et al., Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage, 2000. 8(6): p. 434-43. 2. Kim AL , et al. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J Invest Dermatol. 2005 Jun;124(6):1318-25. 3. Ward, K.W., et al., SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: preclinical pharmacokinetics. Xenobiotica, 2002. 32(3): p. 221-33.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.83 ml 14.149 ml 28.297 ml
    5 mM 0.566 ml 2.83 ml 5.659 ml
    10 mM 0.283 ml 1.415 ml 2.83 ml
    50 mM 0.057 ml 0.283 ml 0.566 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。